HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

6th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 28-30 | Hybrid Event

September 28-30, 2026 | London, UK

Cancer Biotechnology

Cancer Biotechnology

Cancer biotechnology is a multidisciplinary field that leverages advancements in biology, genetics, and technology to understand, diagnose, and treat various forms of cancer. This specialized branch of biotechnology focuses on developing innovative tools, techniques, and therapies to combat the complexities of cancer at the molecular level. Researchers in cancer biotechnology explore the genetic basis of cancer, enabling the identification of specific biomarkers and genetic mutations associated with different types of malignancies. This knowledge is instrumental in the development of targeted therapies and personalized medicine, tailoring treatment approaches to individual patients. Additionally, cancer biotechnology plays a pivotal role in diagnostic technologies, such as molecular imaging and liquid biopsy, offering more precise and less invasive methods for cancer detection. The ongoing advancements in cancer biotechnology hold promise for groundbreaking discoveries and transformative breakthroughs in the relentless pursuit of effective cancer prevention, diagnosis, and treatment strategies.

Committee Members
Speaker at Biotechnology and Bioengineering 2026 - Murray Moo Young

Murray Moo Young

University of Waterloo, Canada
Speaker at Biotechnology and Bioengineering 2026 - Limongi Tania

Limongi Tania

University of Turin, Italy
Speaker at Biotechnology and Bioengineering 2026 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Universidad Autonoma de Baja California, Mexico

Submit your abstract Today

Watsapp